1. Home
  2. ARTL vs PAVS Comparison

ARTL vs PAVS Comparison

Compare ARTL & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.00

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

SELL

Current Price

$5.81

Market Cap

4.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ARTL
PAVS
Founded
2011
2004
Country
United States
United States
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ARTL
PAVS
Price
$1.00
$5.81
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
187.8K
38.2M
Earning Date
05-13-2026
07-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.02
52 Week High
$28.60
$26.69

Technical Indicators

Market Signals
Indicator
ARTL
PAVS
Relative Strength Index (RSI) 26.93 71.14
Support Level N/A $0.47
Resistance Level $1.87 $9.92
Average True Range (ATR) 0.08 0.62
MACD 0.04 0.57
Stochastic Oscillator 1.58 57.99

Price Performance

Historical Comparison
ARTL
PAVS

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

Share on Social Networks: